{"abdominal pain": 2.36, "alopecia": 3.14, "anaemia": 2.61, "ascites": 7.7, "carcinoid crisis": 789.4, "disease progression": 12.96, "flushing": 7.26, "general physical health deterioration": 10.56, "haematotoxicity": 39.7, "haemoglobin decreased": 2.14, "hepatic failure": 4.08, "ill-defined disorder": 125.03, "illness": 3.68, "inappropriate schedule of product administration": 3.59, "intentional product use issue": 6.81, "intestinal obstruction": 12.18, "jaundice": 2.96, "laboratory test abnormal": 13.18, "leukopenia": 6.77, "lymphopenia": 34.01, "maligt neoplasm progression": 11.87, "metastases to liver": 18.53, "myelodysplastic syndrome": 20.61, "neoplasm progression": 4.98, "neuroendocrine tumour": 424.41, "neutropenia": 3.94, "pancreatic neuroendocrine tumour": 164.57, "pancytopenia": 4.97, "platelet count decreased": 5.81, "renal impairment": 3.27, "thrombocytopenia": 17.14}